Ortiz-Bautista RJ, García-González LL, Ocádiz-González MA, Flores-Tochihuitl J, García-Villaseñor A, González-Hernández M, Muñoz-Hernández L, Ortiz-Figueroa MC, Ramírez-Anaya M, Reyna-Téllez S, Villanueva-Sánchez O

Language: Spanish
References: 25
Page: 587-593
PDF size: 482.79 Kb.

ABSTRACT

Introduction: Matricaria Chamomilla L. (Mch), popularly known as chamomile, has been used for centuries as an herbolary remedy due to its broad clinical spectrum. The aim of this study was to evaluate the effect of Mch associated to a vehicle with emollient function in induced atopic dermatitis (AD)-like lesions in a murine model.
Methodology: AD was induced with dinitrochlorobenzene on 12 male seven-week old BALB/c mice. Animals were divided in three groups (control, GC; control negative, GCN; and experimental, GE). Liquid petrolatum was applied to the GCN and liquid petrolatum with aqueous extract of Mch at 7% to the GE. Induction and evolution of the lesions were verified by biopsy at 2nd and 6th week. Evaluation of peripheral blood cells to correlate inflammatory cells was made as well at the same weeks. Lesions were clinically evaluated at 2nd, 4th and 6th week. Scratching was monitored according to the observation methodology of Kobayashi et al.
Results: Mch aqueous extract associated to a vehicle with emollient function improves atopic dermatitis-like lesions after two weeks.

REFERENCES

1. Saeki H, Furue M, Furukawa F, Hide M, Ohtsuki M, Katayama I et al. Guidelines for management of atopic dermatitis. J Dermatol. 2009;36(10):563-577.

2. Loden M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 2003;4(11):771-788.

3. McHenry PM, Williams HC, Bingham EA. Management of atopic eczema: Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London. BMJ. 1995;310(6983):843-847.

4. Brown DJ, Dattner AM. Phytotherapeutic Approaches to common dermatologic conditions. Arch Dermatol. 1998;134(11):1401-1404.

5. Bisset NG, Wichtl M. Herbal drugs and phytopharmaceuticals. Second edition. Florida, USA: CRC Press; 2001.

6. Pino JA, Bayat F, Marbot R, Aguero J. Essential oil of chamomile Chamomilla recutita (L.) Rausch. from Iran. J Essent Oil Res. 2002;14:407-408.

7. Pino JA, Marbot R, Aguero J, Fuentes V. Essential oil of chamomile Chamomilla recutita (L.) Rausch. from Cuba. J Essent Oil Bear Pl. 2000;3(1):1-3.

8. Mann C, Staba EJ. The chemistry, pharmacology, and commercial formulations of Chamomile. En: Herbs, Spices, and Medicinal Plants: Recent Advances in Botany, Horticulture, and Pharmacology. Volumen 1. Phoenix, USA: Oryx Press; 1986.

9. Matos FJA, Machado MIL, Alencar JW, Craveiro AA. Constituents of Brazilian chamomile oil. J Essent Oil Res. 1993;5(3):337-339.

10. Mimica-Dukic N, Lukic V, Pavkov R, Gasic O. Study of chemical composition and microbiological contamination of chamomile tea. Acta Hort. 1993;333:137-141.

11. Stanev S, Zheljazkov V, Janculoff Y. Variation of chemical compounds in the essential oil from some native forms of chamomile (Chamomilla recutita L.). Beitr Zuchtungsforschung. 1996;2:214-217.

12. Eisenburg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs and pattern uses. N Engl J Med. 1993;328(4):246-252.

13. Norma Oficial Mexicana NOM-062-ZOO-1999, Especificaciones técnicas para la producción, cuidado y uso de los animales de laboratorio. Recuperada el 1 de enero de 2012. Disponible en: http://www.fmvz.unam.mx/fmvz/principal/ archivos/062ZOO.PDF

14. Canadian Council on Animal Care guidelines on: Choosing appropriate endpoint in experiments using animals for research, teaching and testing. 1998. Recuperada el 1 de enero de 2012. Disponible en: http://www.ccac.ca/Documents/Standards/ Guidelines/Appropriate_endpoint.pdf

15. Kobayashi Y, Takahashi R, Ogino F. Antipruritic effect of the single oral administration of German chamomile flower extract and its combined effect with antiallergic agents in ddY mice. J Ethnopharmacol. 2005;101(1-3):308-312.

16. Hampton AL, Hish GA, Aslam MN, Rothman ED, Bergin IL, Patterson KA et al. Progression of Ulcerative Dermatitis Lesions in C57BL/6Crl Mice and the Development of a Scoring System for Dermatitis Lesions. J Am Assoc Lab Anim Sci. 2012;51(5):586-593.

17. Harlan Laboratories, Inc. BALB/c. Bagg’s Albino. 2008. Recuperado el 1 de enero de 2012. Disponible en: www.harlan.com

18. Man MQ, Hupe M, Sun R, Man G, Mauro TM, Elias PM. Apigenin Alleviates Cutaneous Inflammation in Murine Models. Evidence-Based Complementary and Alternative Medicine. 2012:1-7.

19. Boerjan W, Ralph J, Baucher M. Lignin Biosyntesis. Annu Rev Plant Biol. 2003;54:519-546.

20. Olthof MR, Hollman PCH, Katan MB. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr. 2001;131(1):66-71.

21. Wood M. Nuts’ new aflatoxin fighter: Caffeic acid? Agricultural Research. 2006;54(10):9

22. Sharp JL, Zammit TG, Azar TA, Lawson DM. Stresslike responses to common procedures in male rats housed alone or with other rats. Contemporary Topics. 2002;41(4):8-14.

23. Soon-Hee L, Yong H, Young-Chul K. Effect of German chamomile oil application on alleviating atopic dermatitis-like immune alterations in mice. J Vet Sci. 2010;11(1):35-41.

24. Patzelt-Wenczler R, Ponce-Pöschl E. Proof of efficacy of Kamillosan(R) cream in atopic eczema. Eur J Med Res. 2000;5(4):171-175.

25. Dattner AM. From medical herbalism to phytotherapy in dermatology: back to the future. Dermatol Ther 2004;16(2):106-113.